Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
British pharmaceutical giant AstraZeneca on Tuesday announced plans to invest $50 billion in the United States, including the construction of a multi-billion-dollar manufacturing facility in Virginia—its largest-ever single manufacturing investment—amid rising pressure from the Trump administration’s tariff push.The company said it expects 50% of its total revenue to come from the US by 2030, underlining…